Long intragenic non-coding RNA lincRNA-p21 suppresses development of human prostate cancer

Xiaohai Wang1, Yuan Ruan1, Xingjie Wang1

  • 1Department of Urology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Cell Proliferation
|December 16, 2016
PubMed
Abstract

Insights

Long non-coding RNA p21 (lincRNA-p21) is down-regulated in prostate cancer, inhibiting tumor growth and promoting apoptosis. Its regulation of p53 downstream genes suggests a tumor-suppressive role in prostate cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer is a leading malignancy in men globally, with complex underlying mechanisms.
  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in human cancer development.
  • The specific function of lincRNA-p21 in prostate cancer pathogenesis requires elucidation.

Purpose of the Study:

  • To investigate the role of lincRNA-p21 in the development of human prostate cancer.
  • To explore the molecular mechanisms by which lincRNA-p21 influences prostate cancer progression.

Main Methods:

  • Real-time PCR was used to assess lincRNA-p21 expression in prostate cancer cell lines and tissues.
  • Lentiviral vectors were employed to manipulate lincRNA-p21 levels, assessing effects on cell proliferation and apoptosis.
  • In vivo studies utilized a mouse xenograft model to evaluate lincRNA-p21's impact on tumor growth.
  • Western blotting and chromatin immunoprecipitation analyzed the relationship between lincRNA-p21 and p53 downstream genes.

Main Results:

  • LincRNA-p21 was found to be down-regulated in human prostate cancer tissues, correlating with advanced disease stage and poor survival.
  • Overexpression of lincRNA-p21 inhibited prostate cancer cell proliferation and colony formation in vitro and reduced tumor growth in vivo.
  • LincRNA-p21 was shown to promote apoptosis and induce p53 downstream gene expression by regulating p53 binding to their promoters.
  • Reduced expression of p53 downstream genes in malignant prostate tissues correlated with lower lincRNA-p21 levels.

Conclusions:

  • LincRNA-p21 acts as a tumor suppressor in human prostate cancer.
  • Its inhibitory effects are partly mediated through the regulation of p53 downstream gene expression.
  • Apoptotic activation by lincRNA-p21 also contributes to its anti-cancer role in prostate cancer development.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.8K